tradingkey.logo

NLS Pharmaceutics AG

NLSPW
View Detailed Chart
0.018USD
0.000
Close 12/24, 13:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

NLS Pharmaceutics AG

0.018
0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

+17.76%

Year to Date

+37.69%

1 Year

+59.82%

View Detailed Chart

TradingKey Stock Score

No stock score available due to insufficient data.

NLS Pharmaceutics AG News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

NLS Pharmaceutics AG Info

NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Ticker SymbolNLSPW
CompanyNLS Pharmaceutics AG
CEOMr. Alexander Zwyer
Websitehttps://nlspharma.com/

FAQs

What is the current price of NLS Pharmaceutics AG (NLSPW)?

The current price of NLS Pharmaceutics AG (NLSPW) is 0.018.

What is the symbol of NLS Pharmaceutics AG?

The ticker symbol of NLS Pharmaceutics AG is NLSPW.

What is the 52-week high of NLS Pharmaceutics AG?

The 52-week high of NLS Pharmaceutics AG is 4.740.

What is the 52-week low of NLS Pharmaceutics AG?

The 52-week low of NLS Pharmaceutics AG is 0.740.

What is the market capitalization of NLS Pharmaceutics AG?

The market capitalization of NLS Pharmaceutics AG is --.

What is the net income of NLS Pharmaceutics AG?

The net income of NLS Pharmaceutics AG is --.

Is NLS Pharmaceutics AG (NLSPW) currently rated as Buy, Hold, or Sell?

According to analysts, NLS Pharmaceutics AG (NLSPW) has an overall rating of --, with a price target of --.

What is the Earnings Per Share (EPS TTM) of NLS Pharmaceutics AG (NLSPW)?

The Earnings Per Share (EPS TTM) of NLS Pharmaceutics AG (NLSPW) is --.
KeyAI